<!DOCTYPE html><html xml:lang="en" lang="en" xmlns="http://www.w3c.org/1999/xhtml">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <title>P_HEPBD</title>
    <meta name="title" content="NHANES 2017-March 2020: Hepatitis B: Core antibody, Surface antigen, and Hepatitis D antibody  Data Documentation, Codebook, and Frequencies" />
    <style type="text/css">
					.nhanes-doc { font: 75% Verdana, Arial, Helvetica, sans-serif; }

					.nhanes-doc h1 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 2em;
					font-weight: normal;
					margin-bottom: 10px;
					margin-top: 0;
					}

					.nhanes-doc h2 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.6em;
					font-weight: normal;
					}

					.nhanes-doc h3 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.5em;
					font-weight: normal;
					}

					.nhanes-doc h3.vartitle {
					background-color: #c1d5b0;
					padding: 6px 12px;
					}

					.nhanes-doc h4 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.3em;
					font-weight: bold;
					}

					.nhanes-doc h5 {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					font-weight: bold;
					}

					.nhanes-doc h5.specialnote {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1.2em;
					font-weight: bold;
					margin-left: 3em;
					}

					.nhanes-doc a {
					color: #039;
					text-decoration: none;
					}

					.nhanes-doc p {
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					line-height: 1.33em;
					padding: 0 3em 1em;
					text-align: left;
					}

					.nhanes-doc ol,
					.nhanes-doc ul {
					margin-left: 2.4em;
					margin-bottom: 1.2em;
					}

					.nhanes-doc ul {
					list-style-type: disc;
					}

					.nhanes-doc ol {
					list-style-type: decimal;
					}

					.nhanes-doc li {
					margin-top: 0.6em;
					}

					.nhanes-doc #toc ul,
					.nhanes-doc #References ul {
					margin-left: 0em;
					}

					.nhanes-doc #Sections ol ul,
					.nhanes-doc #Sections ul ul {
					margin-left: 0;
					}

					.nhanes-doc #Sections ol ol,
					.nhanes-doc #Sections ul ol {
					margin-left: -1.2em;
					}

					.nhanes-doc #Sections li {
					margin-left: 1.2em;
					}

					.nhanes-doc table {
					border: #000 1px solid;
					border-collapse: collapse;
					margin: 0 auto 1em;
					max-width: 600px;
					padding: 2px;
					page-break-inside: avoid;
					table-layout: auto;
					}

					.nhanes-doc th {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc th.rowheader {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc td {
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: left;
					vertical-align: top;
					}

					.nhanes-doc td p {
					margin: inherit;
					padding: 0;
					}

					.nhanes-doc td.values2 {
					text-align: RIGHT;
					vertical-align: top;
					}

					.nhanes-doc table caption {
					font-weight: bold;
					padding-bottom: 0.5em;
					}

					.nhanes-doc div#wrapper { width: 650px; }

					.nhanes-doc div#toc {
					border: solid 1px #CCC;
					float: left;
					height: 95%;
					left: 750px;
					overflow: hidden;
					position: fixed;
					top: 10px;
					width: 400px;
					z-index: 10;
					}

					.nhanes-doc div#toc h3 {
					background-color: #f4f4e1;
					border-bottom: solid 1px #ccc;
					letter-spacing: 8px;
					margin: 0;
					padding: 8px;
					text-align: center;
					text-transform: uppercase;
					}

					.nhanes-doc div#toc-scroll {
					height: calc(100% - 1.5em);
					overflow: scroll;
					width: 100%;
					}

					.nhanes-doc div#toc li {
					margin-left: -0.5em;
					margin-right: -0.5em;
					}

					.nhanes-doc div#PageHeader {
					border-bottom: thin solid #999;
					margin-bottom: 12px;
					width: 650px;
					}

					.nhanes-doc div#Sections { width: 650px; }

					.nhanes-doc div#Codebook { width: 650px; }

					.nhanes-doc div#Codebook dl {
					margin: 2em 0 10px 40px;
					padding: 0;
					width: 600px;
					display: table;
					}

					.nhanes-doc div#Codebook dt {
					float: left;
					font-weight: bold;
					margin: 0;
					padding: 0.5em;
					width: 150px;
					display: table-cell;
					}

					.nhanes-doc div#Codebook dd {
					float: left;
					margin: 0;
					padding: 0.5em;
					width: 420px;
					display: table-cell;
					}

					.nhanes-doc div#References {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc div#References li {
					word-wrap: break-word;
					}

					.nhanes-doc div#Appendix {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc table.values {
					border: 2px;
					left: 20px;
					margin-bottom: 20px;
					page-break-inside: avoid;
					position: relative;
					width: 600px;
					}

					.nhanes-doc span.file-size { color: gray; }

					.nhanes-doc .pagebreak {
					background-color: transparent;
					display: block;
					page-break-after: always;
					page-break-inside: avoid;
					}
				</style>
    <style type="text/css" media="print">
					.nhanes-doc div#toc { display: none; }
				</style>
  </head>
  <body class="nhanes-doc">
    <div id="toc">
      <h3>Table of Contents</h3>
      <div id="toc-scroll">
        <ul>
          <li>
            <a href="#Component_Description">Component Description</a>
          </li>
          <li>
            <a href="#Eligible_Sample">Eligible Sample</a>
          </li>
          <li>
            <a href="#Description_of_Laboratory_Methodology">Description of Laboratory Methodology</a>
          </li>
          <li>
            <a href="#Laboratory_Method_Files">Laboratory Method Files</a>
          </li>
          <li>
            <a href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</a>
          </li>
          <li>
            <a href="#Data_Processing_and_Editing">Data Processing and Editing</a>
          </li>
          <li>
            <a href="#Analytic_Notes">Analytic Notes</a>
          </li>
          <li>
            <a href="#References">References</a>
          </li>
          <li>
            <a href="#Codebook">Codebook</a>
            <ul id="CodebookLinks">
              <li>
                <a href="#SEQN">SEQN - Respondent sequence number</a>
              </li>
              <li>
                <a href="#LBXHBC">LBXHBC - Hepatitis B core antibody</a>
              </li>
              <li>
                <a href="#LBDHBG">LBDHBG - Hepatitis B surface antigen</a>
              </li>
              <li>
                <a href="#LBDHD">LBDHD - Hepatitis D antibody (anti-HDV)</a>
              </li>
            </ul>
          </li>
        </ul>
      </div>
    </div>
    <div id="wrapper">
      <div id="PageHeader">
        <h1>National Health and Nutrition Examination Survey</h1>
        <h2>2017-March 2020 Data Documentation, Codebook, and Frequencies</h2>
        <h3>Hepatitis B: Core antibody, Surface antigen, and Hepatitis D antibody  (P_HEPBD)</h3>
        <h4> Data File: P_HEPBD.xpt</h4>
        <h5 class="left">First Published: August 2022</h5>
        <h5 class="right">Last Revised: NA</h5>
      </div>
      <div id="Sections">
        <h2 id="Component_Description">Component Description</h2><p>The NHANES program suspended field operations in
March 2020 due to the coronavirus disease 2019 (COVID-19) pandemic. As a
result, data collection for the NHANES 2019-2020 cycle was not completed and
the collected data are not nationally representative. Therefore,
data collected from 2019 to March 2020 were combined with data from the NHANES
2017-2018 cycle to form a nationally representative sample of NHANES 2017-March
2020 pre-pandemic data. These data are available to the public. Please refer to
the Analytic Notes section for more details on the use of the data.</p>
<p>Hepatitis viruses
constitute a major public health problem because of the morbidity and mortality
associated with the acute and chronic consequences of these infections.&nbsp;Because of the
high rate of asymptomatic infection with these viruses, information about the
prevalence of these diseases is needed to monitor prevention efforts. By
testing a nationally representative sample of the U.S. population, NHANES will
provide the most reliable estimates of age-specific prevalence needed to
evaluate the effectiveness of the strategies to prevent these infections. In
addition, NHANES provides the means to better define the epidemiology of other
hepatitis viruses. NHANES testing for markers of infection with hepatitis
viruses is used to determine secular trends in infection rates across most age
and racial/ethnic groups and will provide a national picture of the
epidemiologic determinants of these infections.</p>
<p>Hepatitis is inflammation of the liver most
often caused by a virus. Viral hepatitis is a major public health problem of
global importance because of the ongoing transmission of viruses that cause the
disease and increased morbidity and mortality associated with the acute and
chronic consequences of these infections. Global and US goals have been
established for elimination of viral hepatitis as a public health threat by
2030 (HHS Healthy People, 2022 and HHS 2020). </p>
<p>In the US, the most common types of viral
hepatitis are hepatitis A, B, and C. Effective vaccines are available to help
prevent hepatitis A and hepatitis B. No vaccine is available for hepatitis C;
however, highly effective, well-tolerated treatment can cure hepatitis C virus
infection. Hepatitis D virus infection is less common in the US and can occur
only among persons with hepatitis B virus infection. Hepatitis E infection also
is less common in the US. These five hepatitis viruses, also called
hepatitides, are well-characterized for detection with laboratory assays and
are monitored in U.S. public health surveillance systems.</p>
<p>NHANES viral hepatitis data are used to monitor
progress toward goals in <em>Healthy People </em>and the HHS <em>Viral Hepatitis
National Strategic Plan</em>, which in turn support US and global viral
hepatitis elimination goals (HHS Healthy People, 2022 and NASEC, 2017). The
viral hepatitis laboratory and interview components of NHANES complement data
from outbreak, case-based surveillance, vital statistics, health care systems,
and cohort studies that can provide timely, detailed, or longitudinal
information for subnational geographic areas and disproportionately affected
populations, such as persons experiencing homelessness or living in
correctional facilities; however, these sources lack information available from
NHANES, such as race, ethnicity, education, income, and health status and
behaviors. </p>
<p>Viral hepatitis data from NHANES are available
beginning with the Second NHANES conducted during 1976-1980 for hepatitis A and
hepatitis B, and with the Third NHANES conducted during 1988-1994 for hepatitis
C, hepatitis D and hepatitis E. </p>
<p>An estimated 300 million people worldwide
are persistent carriers of hepatitis B virus (HBV). Infection with HBV results
in a wide spectrum of acute and chronic liver diseases that may lead to
cirrhosis and hepatocellular carcinoma. Co-infection with hepatitis D virus
(HDV) in persons with acute or chronic hepatitis B virus (HBV) infection can
lead to fulminant hepatitis. </p>
<p>Transmission of HBV occurs by
percutaneous exposure to blood products and contaminated instruments, sexual
contact and perinatally from HBV-infected mothers to their unborn child. </p>
<p>HBV infection produces an array of
unique antigens and antibody responses that, in general, follow distinct
serological patterns.</p>
<p>Hepatitis B surface antigen
(HBsAg), derived from the viral envelope, is the first antigen to appear
following infection and can be detected serologically as an aid in the
laboratory diagnosis of acute HBV infection.</p>
<p>Hepatitis B core antibody (anti-HBc)
is detectable shortly after the appearance of hepatitis B surface antigen
(HBsAg). As the appearance of anti-HBsAg may be delayed after HBsAg clearance,
anti-HBc is sometimes the only serological marker for HBV infection and
potentially infectious blood. Anti-HBc is found in acute and chronic hepatitis
B patients and also indicates past resolved infection.</p>
<p>The Delta antigen/antibody system
(HDAg/Anti-HDV) is related to HBV infection but immunologically distinct from
its known reactivities; it is the expression of the Delta virus (Hepatitis D
Virus, HDV), a cause of severe liver disease in HBsAg carriers. HDV is a
35-37nm particle containing low molecular weight RNA and HDAg, with an outer
coat of HBsAg obtained from HBV. HDV is a defective virus and its replication
requires helper functions provided by HBV. HDAg has been detected in liver and
in serum and induces a specific antibody response (anti-HDV antibodies) in both
the IgG and IgM classes.</p>
<p>Tests for anti-HBc, HBsAg, and
anti-HDV are conducted as part of the NHANES viral hepatitis component.</p><h2 id="Eligible_Sample">Eligible Sample</h2><p>Examined
participants aged 6 years or older in the NHANES 2017-March 2020
pre-pandemic sample were eligible.</p><h2 id="Description_of_Laboratory_Methodology">Description of Laboratory Methodology</h2><p><strong>Hepatitis B core antibody (anti-HBc)</strong> </p>
<p>Hepatitis B core antibody is measured using
the VITROS Anti-HBc assay, which is performed using the VITROS Anti-HBc Reagent
Pack and VITROS Immunodiagnostic Products Anti-HBc Calibrator on the VITROS
ECi/ECiQ or VITROS 3600 Immunodiagnostic System.</p>
<p>The hepatitis B
core antibody test is performed on all examined participants aged 6 years and
older while the hepatitis B surface antibody test is performed on all examined
participants aged 2 years old and older (reported in <a href="https://wwwn.cdc.gov/Nchs/Nhanes/2017-2018/P_HEPB_S.htm">P_HEPB_S</a>).&nbsp;</p>
<p><strong>Hepatitis B
surface antigen (HBsAg)</strong></p>
<p>Hepatitis B surface antigen is measured using
the VITROS HBsAg test, which is performed using the VITROS HBsAg Reagent Pack
and VITROS Immunodiagnostic Products HBsAg Calibrator on the VITROS ECi/ECiQ
Immunodiagnostic Systems and the VITROS 3600 Immunodiagnostic System.</p>
<p>The Hepatitis B
surface antigen is tested only when the Hepatitis B core antibody test is
positive or indeterminate. </p>
<p><strong>Hepatitis D antibody (anti-HDV) &nbsp;<br />
</strong><br />
Hepatitis D antibody was measured using the DiaSorin
ETI-AB-DELTAK-2 assay during 2017-2018 and the Anti-HDV IgG WES Assay during
January 2019 through March 2020.</p>
<p>The Hepatitis Delta Virus (HDV) is a RNA defective virus; and an infection
with HDV only occurs in the presence of acute or chronic HBV infection. In NHANES, the test for antibody to HDV is performed on
all examined participants 6 years and older who test positive or indeterminate for
anti-HBc and HBsAg.</p>
<p>Refer to the
Laboratory Method Files section for a detailed description of the laboratory
methods used.</p><h2 id="Laboratory_Method_Files">Laboratory Method Files</h2>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/labmethods/HEPBD-J-MET-HEPATITIS-B-CORE-ANTIBODY-508.pdf">Hepatitis B Core Antibody</a>
          <span> (February 2020)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/labmethods/HEPBD-J-MET-HEPATITIS-B-SURFACE-ANTIGEN-508.pdf">Hepatitis B Surface Antigen</a>
          <span> (February 2020)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/labmethods/HEPBD-J-MET-HEPATITIS-D-ANTIBODY-508.pdf">Hepatitis D Antibody</a>
          <span> (February 2020)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/2019-2020/labmethods/HEPBD-K-MET-HEPATITIS-D-ANTIBODY-508.pdf">Hepatitis D Antibody</a>
          <span> (August 2022)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/2019-2020/labmethods/HEPBD-K-MET-HEPATITIS-B-SURFACE-ANTIGEN-508.pdf">Hepatitis B Surface Antigen</a>
          <span> (August 2022)</span>
        </p>
        <p>
          <a target="_blank" href="https://wwwn.cdc.gov/nchs/data/nhanes/2019-2020/labmethods/HEPBD-K-MET-HEPATITIS-B-CORE-ANTIBODY-508.pdf">Hepatitis B Core Antibody</a>
          <span> (August 2022)</span>
        </p>
        <h2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality Assurance and Monitoring</h2><p>Serum samples were
processed, stored, and shipped to the Division of Viral Hepatitis, National
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for
Disease Control and Prevention, Atlanta, GA for analysis.</p>
<p>Detailed
instructions on specimen collection and processing are discussed in the <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/manuals/2017_MEC_Laboratory_Procedures_Manual.pdf">2017-2018</a> and <a href="https://wwwn.cdc.gov/nchs/data/nhanes/2019-2020/manuals/2020-MEC-Laboratory-Procedures-Manual-508.pdf">2019-2020</a> NHANES Laboratory
Procedures Manuals (LPMs). Vials were stored under appropriate frozen (&ndash;30&deg;C)
conditions until they were shipped to Division of Viral Hepatitis, National
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention for testing.</p>
<p>The NHANES quality
assurance and quality control (QA/QC) protocols meet the 1988 Clinical
Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed
in the NHANES LPMs.</p>
<p><strong>Mobile Examination
Centers (MECs) </strong></p>
<p>Laboratory team
performance is monitored using several techniques. NCHS and contract
consultants use a structured competency assessment evaluation during visits to
evaluate both the quality of the laboratory work and the QC procedures. Each
laboratory staff member is observed for equipment operation, specimen
collection and preparation; testing procedures and constructive feedback are
given to each staff member. Formal retraining sessions are conducted annually
to ensure that required skill levels were maintained.</p>
<p><strong>Analytical
Laboratories</strong></p>
<p>NHANES uses
several methods to monitor the quality of the analyses performed by the
contract laboratories. In the MEC, these methods include performing blind split
samples collected on &ldquo;dry run&rdquo; sessions. In addition, contract laboratories
randomly perform repeat testing on 2% of all specimens.</p><h2 id="Data_Processing_and_Editing">Data Processing and Editing</h2><p>The data were
reviewed. Incomplete data or improbable values were sent to the performing
laboratory for confirmation.</p><h2 id="Analytic_Notes">Analytic Notes</h2><p>The COVID-19 pandemic required suspension of
NHANES 2019-2020 field operations in March 2020 after data were collected in 18
of the 30 survey locations in the 2019-2020 sample. Data collection was
cancelled for the remaining 12 locations. Because the collected data from 18
locations were not nationally representative, these data were combined with
data from the previous cycle (2017-2018) to create a 2017-March 2020
pre-pandemic data file. A special weighting process was applied to the
2017-March 2020 pre-pandemic data file. The resulting sample weights in the
demographic data file should be used to calculate estimates from the combined
cycles. These sample weights are not appropriate for independent analyses of
the 2019-2020 data and will not yield nationally representative results for
either the 2017-2018 data alone or the 2019-March 2020 data alone. Please refer
to the NHANES website for additional information for the NHANES 2017-March 2020
pre-pandemic data, and for the previous 2017-2018 public use data file with
specific weights for that 2-year cycle. </p>
<p>Refer to the <a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2017">2017-2018</a> and <a href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2019">2019-2020</a> Laboratory Data
Overview for general information on NHANES laboratory data.</p>
<p>There are over 800
laboratory tests performed on NHANES participants. However, not all
participants provided biospecimens or enough volume for all the tests to be
performed. The specimen availability can also vary by age or other population
characteristics. For example, in 2017-March 2020 approximately 76% of children aged 1-17 years who were examined in the MEC
provided a blood specimen through phlebotomy, while 95% of examined adults aged
18 and older provided a blood specimen. Analysts should evaluate the extent of missing
data in the dataset related to the outcome of interest as well as any predictor
variables used in the analyses to determine whether additional re-weighting for
item non-response is necessary.</p>
<p>Please refer to
the NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx">Analytic Guidelines </a>and the on-line NHANES <a href="https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx">Tutorial</a>
for further details on the use of sample weights and other analytic issues.</p>
<p><strong>Demographic and
Other Related Variables</strong></p>
<p>The analysis of
NHANES laboratory data must be conducted using the appropriate survey design
and demographic variables. The NHANES
<a href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&amp;Cycle=2017-2020">2017 &ndash; March 2020Demographics File</a>&nbsp;contains demographic data, health indicators,
and other related information collected during household interviews as well as
the sample design variables. The recommended procedure for variance estimation
requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively)
in the demographic data file.</p>
<p>This laboratory
data file can be linked to the other NHANES data files using the unique survey
participant identifier (i.e., SEQN).</p>
<p><strong>Detection Limits</strong></p>
<p>This data is
qualitative. The use of lower limits of detection (LLODs) is not applicable.</p>
<p><strong>Hepatitis D Antibody
(Delta) Method Change </strong></p>
<p>The
method for Hepatitis D Antibody (delta) changed between survey cycles 2017-2018
and 2019-2020. The commercial kit (Diasorin) used during the 2017-2018 survey
cycle was discontinued by the manufacturer. The Diasorin test had a sensitivity
of 100% (86.7-100) and a specificity of 100% (91.9-100), however, these sensitivity
and specificity were not independently verified due to a lack of well
characterized sample evaluation panel. A CDC laboratory developed test was used
in 2019-2020 survey cycle and had a sensitivity of 96% and a specificity of
97%. The sensitivity and specificity for this newly developed method are verified
using a convenience sample of NHANES specimens and non-NHANES specimens tested
previously using the commercially available kit.</p></div>
      <div id="References">
        <h2>References</h2>
        <ul>
          <li>National Academies of Sciences, Engineering, and Medicine. 2017. A national
strategy for the elimination of hepatitis B and C. Washington, DC: The National
Academies Press. Available from: <a href="http://www.nationalacademies.org/hmd/reports/2017/national-strategy-for-the-elimination-of-hepatitis-b-and-c.aspx">http://www.nationalacademies.org/hmd/reports/2017/national-strategy-for-the-elimination-of-hepatitis-b-and-c.aspx</a></li>
          <li>U.S. Department of Health
and Human Services. 2020. Viral Hepatitis National Strategic Plan for the
United States: A Roadmap to Elimination (2021&ndash;2025). Washington, DC. Available
from: <a href="https://www.hhs.gov/hepatitis/viral-hepatitis-national-strategic-plan/index.html">https://www.hhs.gov/hepatitis/viral-hepatitis-national-strategic-plan/index.html</a></li>
          <li>U.S. Department of Health
and Human Services. Healthy People. 2022. Available from: <a href="https://health.gov/our-work/national-health-initiatives/healthy-people">https://health.gov/our-work/national-health-initiatives/healthy-people</a></li>
        </ul>
      </div>
      <div id="Codebook">
        <h2>Codebook and Frequencies</h2>
        <div class="pagebreak">
          <h3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">SEQN</dd>
            <dt>SAS Label: </dt>
            <dd>Respondent sequence number</dd>
            <dt>English Text: </dt>
            <dd class="info">Respondent sequence number</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBXHBC">LBXHBC - Hepatitis B core antibody</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBXHBC</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis B core antibody</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis B core antibody</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">641</td>
                <td class="values" align="right">641</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">10275</td>
                <td class="values" align="right">10916</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Indeterminate</td>
                <td class="values" align="right">1</td>
                <td class="values" align="right">10917</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">1281</td>
                <td class="values" align="right">12198</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDHBG">LBDHBG - Hepatitis B surface antigen</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDHBG</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis B surface antigen</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis B surface antigen</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">45</td>
                <td class="values" align="right">45</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">595</td>
                <td class="values" align="right">640</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Indeterminate</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">640</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">11558</td>
                <td class="values" align="right">12198</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
        <div class="pagebreak">
          <h3 class="vartitle" id="LBDHD">LBDHD - Hepatitis D antibody (anti-HDV)</h3>
          <dl>
            <dt>Variable Name: </dt>
            <dd class="info">LBDHD</dd>
            <dt>SAS Label: </dt>
            <dd>Hepatitis D antibody (anti-HDV)</dd>
            <dt>English Text: </dt>
            <dd class="info">Hepatitis D antibody (anti-HDV)</dd>
            <dt>Target: </dt>
            <dd> Both males and females 6 YEARS -
			150 YEARS</dd>
          </dl>
          <table class="values">
            <thead>
              <tr>
                <th scope="column" class="values">Code or Value</th>
                <th scope="column" class="values">Value Description</th>
                <th scope="column" class="values">Count</th>
                <th scope="column" class="values">Cumulative</th>
                <th scope="column" class="values">Skip to Item</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td scope="row" class="values">1</td>
                <td class="values">Positive</td>
                <td class="values" align="right">6</td>
                <td class="values" align="right">6</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">2</td>
                <td class="values">Negative</td>
                <td class="values" align="right">633</td>
                <td class="values" align="right">639</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">3</td>
                <td class="values">Indeterminate</td>
                <td class="values" align="right">0</td>
                <td class="values" align="right">639</td>
                <td class="values">
                </td>
              </tr>
              <tr>
                <td scope="row" class="values">.</td>
                <td class="values">Missing</td>
                <td class="values" align="right">11559</td>
                <td class="values" align="right">12198</td>
                <td class="values">
                </td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>
    </div>
  </body>
</html>